Patent · US Expired

Neuropeptide Y antagonists

US6900226B2 · kind B2 · utility

0Cited by

6References

76Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Volker Breu · Schliengen, DE
Frank Matthias Dautzenberg · Memmingen, DE
Philippe Guerry · Basel, CH
Matthias Nettekoven · Weil am Rhein, DE
Philippe Pflieger · Schwoben, FR

Key dates

Filing date	Aug 27, 2001
Grant date	May 31, 2005
Priority date	—
Expiry date	Jan 29, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Quinoline and quinazoline derivatives can be used in the form of pharmaceutical preparations as Neuropeptide Y antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.